N03.3 Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis

Name of the Condition

• Chronic Nephritic Syndrome with Diffuse Mesangial Proliferative Glomerulonephritis

Summary

Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis is a kidney disorder characterized by persistent inflammation of the glomeruli, the kidney's filtering units. This condition involves diffuse proliferation of mesangial cells within the glomeruli, leading to gradual loss of kidney function over time. It typically presents with hematuria (blood in urine), proteinuria (excess protein in urine), and hypertension. The underlying glomerular changes contribute to impaired filtration and progressive renal impairment.

Causes

Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis is often associated with immune-mediated processes, such as abnormal immune complex deposition or dysregulated immune responses. It may result from underlying conditions like IgA nephropathy, post-infectious glomerulonephritis, or other glomerular diseases. In some cases, the exact cause remains unclear, but the condition is marked by ongoing inflammation and structural changes in the glomeruli.

Risk Factors

• Autoimmune disorders: Conditions like lupus or vasculitis that trigger glomerular inflammation.
• Genetic factors: Family history of kidney disease or inherited glomerular disorders.
• Infections: Persistent or recurrent infections that affect kidney function.
• Medications: Long-term use of drugs known to cause nephrotoxicity.
• Chronic kidney disease: Pre-existing kidney damage increases susceptibility.

Symptoms

• Hematuria (blood in urine)
• Proteinuria (excess protein in urine)
• Edema (swelling, particularly in the legs and ankles)
• Hypertension (high blood pressure)
• Reduced kidney function
• Fatigue or malaise

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urinalysis detects hematuria and proteinuria, while blood tests assess kidney function (e.g., creatinine, BUN) and rule out other causes. A kidney biopsy is often performed to confirm diffuse mesangial proliferative changes and exclude other glomerular diseases. Imaging studies, such as ultrasound, may evaluate kidney structure and size.

Treatment Options

Treatment focuses on managing symptoms and slowing disease progression. This may include medications to control blood pressure (e.g., ACE inhibitors, ARBs), reduce proteinuria, and suppress immune responses (e.g., corticosteroids, immunosuppressants). Dietary modifications, such as limiting sodium and protein, and managing underlying conditions (e.g., infections, autoimmune diseases) are also important. In advanced cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the severity of kidney damage and response to treatment. Early intervention can slow progression, but chronic nephritic syndrome often leads to gradual renal impairment over time. Regular follow-up with a nephrologist is essential to monitor kidney function, adjust treatments, and manage complications. Long-term outcomes depend on adherence to therapy and control of risk factors.

Complications

• Progressive kidney failure
• End-stage renal disease (ESRD)
• Cardiovascular disease (e.g., hypertension, heart disease)
• Electrolyte imbalances
• Anemia
• Edema-related complications (e.g., skin infections)

Lifestyle & Prevention

• Maintain a balanced diet low in sodium and protein.
• Control blood pressure and blood sugar (if applicable).
• Avoid nephrotoxic medications (e.g., NSAIDs) unless prescribed.
• Stay hydrated and manage infections promptly.
• Avoid smoking and limit alcohol consumption.
• Engage in regular physical activity as tolerated.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, proteinuria, unexplained swelling, or worsening kidney function. Prompt evaluation is critical if symptoms like severe hypertension, shortness of breath, or signs of kidney failure (e.g., reduced urine output) occur. Early intervention can help manage complications and slow disease progression.

Tips for Medical Coders

When coding for chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis (ICD-10-CM code N03.3), ensure documentation supports the specific histologic finding of diffuse mesangial proliferation. Verify that the diagnosis aligns with clinical criteria, including persistent nephritic symptoms and biopsy confirmation. Code accurately to reflect the underlying glomerular pathology, as this impacts clinical management and reimbursement. Avoid coding for unrelated conditions or unspecified nephritic syndromes without supporting documentation.